Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

Arthritis Research and Therapy

Volumn 16, Issue 5, 2014, Pages

  Nagai, Toshihiro ^a   Sato, Masato ^a   Kobayashi, Miyuki ^a   Yokoyama, Munetaka ^a   Tani, Yoshiki ^a   Mochida, Joji ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BEVACIZUMAB; CHONDROMODULIN 1; COLLAGEN TYPE 2; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; JOINT; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; RABBIT MODEL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGERY; SYNOVIUM; TREATMENT OUTCOME;

AGGRECANS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ANTIBODIES, MONOCLONAL, HUMANIZED; BEVACIZUMAB; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRAVENOUS; JOINTS; OSTEOARTHRITIS; OSTEOPHYTE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907961820     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0427-y     Document Type: Article

References (40)

1. Steadman JR, Rodkey WG, Briggs KK, Rodrigo JJ. The microfracture technic in the management of complete cartilage defects in the knee joint. [Article in German]. Orthopade 1999, 28:26-32. 10081041.
2. Szerb I, Hangody L, Duska Z, Kaposi NP. Mosaicplasty: long-term follow-up. Bull Hosp Jt Dis 2005, 63:54-62. 16536220.
3. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895. 10.1056/NEJM199410063311401, 8078550.
4. Moseley JB, Anderson AF, Browne JE, Mandelbaum BR, Micheli LJ, Fu F, Erggelet C. Long-term durability of autologous chondrocyte implantation: a multicenter, observational study in US patients. Am J Sports Med 2010, 38:238-246. 10.1177/0363546509348000, 20448191.
5. Buckwalter JA, Lohmander S. Operative treatment of osteoarthrosis. Current practice and future development. J Bone Joint Surg Am 1994, 76:1405-1418. 8077274.
6. Freed LE, Grande DA, Lingbin Z, Emmanual J, Marquis JC, Langer R. Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res 1994, 28:891-899. 10.1002/jbm.820280808, 7983087.
7. Marcacci M, Berruto M, Brocchetta D, Delcogliano A, Ghinelli D, Gobbi A, Kon E, Pederzini L, Rosa D, Sacchetti GL, Stefani G, Zanasi S. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005, 435:96-105. 10.1097/01.blo.0000165737.87628.5b, 15930926.
8. Mainil-Varlet P, Rieser F, Grogan S, Mueller W, Saager C, Jakob RP. Articular cartilage repair using a tissue-engineered cartilage-like implant: an animal study. Osteoarthr Cartil 2001, 9:S6-S15. 10.1053/joca.2001.0438, 11680690.
9. Nagai T, Furukawa KS, Sato M, Ushida T, Mochida J. Characteristics of a scaffold-free articular chondrocyte plate grown in rotational culture. Tissue Eng Part A 2008, 14:1183-1193. 10.1089/ten.tea.2007.0114, 18433308.
10. Nagai T, Sato M, Furukawa KS, Kutsuna T, Ohta N, Ushida T, Mochida J. Optimization of allograft implantation using scaffold-free chondrocyte plates. Tissue Eng Part A 2008, 14:1225-1235. 10.1089/ten.tea.2007.0225, 18489244.
11. Nagai T, Sato M, Kutsuna T, Kokubo M, Ebihara G, Ohta N, Mochida J: Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair.Arthritis Res Ther 2010, 12:R178.
12. Walsh DA, Haywood L. Angiogenesis: a therapeutic target in arthritis. Curr Opin Investig Drugs 2001, 2:1054-1063. 11892913.
13. Walsh DA, Bonnet CS, Turner EL, Wilson D, Situ M, McWilliams DF. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthr Cartil 2007, 15:743-751. 10.1016/j.joca.2007.01.020, 17376709.
14. Pufe T, Petersen W, Tillmann B, Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001, 44:1082-1088. 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X, 11352239.
15. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177. 10.1002/art.11094, 12905470.
16. Lotz M. Osteoarthritis year 2011 in review: biology. Osteoarthr Cartil 2012, 20:192-196. 10.1016/j.joca.2011.11.015, 22179031.
17. Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, Giacomelli R. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?. Autoimmun Rev 2011, 10:595-598. 10.1016/j.autrev.2011.04.020, 21545851.
18. Suri S, Gill SE, Massena De Camin S, Wilson D, McWilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007, 66:1423-1428. 10.1136/ard.2006.063354, 17446239.
19. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342. 10.1056/NEJMoa032691, 15175435.
20. Yudoh K, Shishido K, Murayama H, Yano M, Matsubayashi K, Takada H, Nakamura H, Masuko K, Kato T, Nishioka K. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum 2007, 56:3307-3318. 10.1002/art.22917, 17907184.
21. Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, Langmuir V, Rugo HS. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 2005, 23:792-799. 10.1200/JCO.2005.05.098, 15681523.
22. van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J, Kimpen JL, Hoepelman AI, Geelen SP. Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis. J Neuroimmunol 2005, 160:170-177. 10.1016/j.jneuroim.2004.11.013, 15710470.
23. Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol 2006, 142:162-164. 10.1016/j.ajo.2006.03.058, 16815270.
24. Manzano RP, Peyman GA, Khan P, Kivilcim M. Testing intravitreal toxicity of bevacizumab (Avastin). Retina 2006, 26:257-261. 10.1097/00006982-200603000-00001, 16508423.
25. Ohta N, Sato M, Ushida K, Kokubo M, Baba T, Taniguchi K, Urai M, Kihira K, Mochida J: Jellyfish mucin may have potential disease-modifying effects on osteoarthritis.BMC Biotechnol 2009, 9:98.
26. Hayashi M, Muneta T, Takahashi T, Ju YJ, Tsuji K, Sekiya I. Intra-articular injections of bone morphogenetic protein-7 retard progression of existing cartilage degeneration. J Orthop Res 2010, 28:1502-1506. 10.1002/jor.21165, 20872588.
27. Laverty S, Girard CA, Williams JM, Hunziker EB, Pritzker KP. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthr Cartil 2010, 18:S53-S65. 10.1016/j.joca.2010.05.029, 20864023.
28. Shirai T, Kobayashi M, Nishitani K, Satake T, Kuroki H, Nakagawa Y, Nakamura T. Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res 2011, 29:1572-1577. 10.1002/jor.21394, 21462250.
29. Tibesku CO, Szuwart T, Ocken SA, Skwara A, Fuchs S. Increase in the expression of the transmembrane surface receptor CD44v6 on chondrocytes in animals with osteoarthritis. Arthritis Rheum 2005, 52:810-817. 10.1002/art.20949, 15751088.
30. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.
31. Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res 2011, 29:802-809. 10.1002/jor.21359, 21520254.
32. Pufe T, Petersen W, Tillmann B, Mentlein R. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 2001, 28:1482-1485. 11469450.
33. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005, 44:7-16. 10.1093/rheumatology/keh344.
34. Pickarski M, Hayami T, Zhuo Y, Duong Le T: Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis.BMC Musculoskelet Disord 2011, 12:197.
35. Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997, 272:32419-32426. 10.1074/jbc.272.51.32419, 9405451.
36. Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun 1991, 175:971-977. 10.1016/0006-291X(91)91660-5, 1709014.
37. van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthr Cartil 2012, 20:223-232. 10.1016/j.joca.2011.12.003, 22178514.
38. Klinger P, Surmann-Schmitt C, Brem M, Swoboda B, Distler JH, Carl HD, von der Mark K, Hennig FF, Gelse K. Chondromodulin 1 stabilizes the chondrocyte phenotype and inhibits endochondral ossification of porcine cartilage repair tissue. Arthritis Rheum 2011, 63:2721-2731. 10.1002/art.30335, 21391200.
39. Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR. VEGFA is necessary for chondrocyte survival during bone development. Development 2004, 131:2161-2171. 10.1242/dev.01053, 15073147.
40. Kitahara H, Hayami T, Tokunaga K, Endo N, Funaki H, Yoshida Y, Yaoita E, Yamamoto T. Chondromodulin-I expression in rat articular cartilage. Arch Histol Cytol 2003, 66:221-228. 10.1679/aohc.66.221, 14527163.